Skip to main
DLB
DLB logo

Dolby Laboratories (DLB) Stock Forecast & Price Target

Dolby Laboratories (DLB) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

Dolby Laboratories Inc. is experiencing a growing adoption of its Atmos and Vision technologies among original equipment manufacturers (OEMs), indicating a strengthening market presence and increased demand for its advanced audio and imaging solutions. The company anticipates that profit growth will outpace revenue growth, driven by operating leverage and the high gross margins characteristic of its business model. Additionally, the stability in foundational revenue trends is likely to enhance the overall revenue growth as the adoption of Dolby's technologies continues to expand.

Bears say

Dolby Laboratories has been experiencing pressure on its foundational revenue trends, attributed largely to tariff uncertainties, which have not aligned with the company’s initial expectations for fiscal 2025. The aftermath of the pandemic has exacerbated these pressures, as foundational revenues have struggled to recover following an initial spike in device purchases during that period. Consequently, this combination of external economic factors and ongoing revenue challenges contributes to a negative outlook for the company.

Dolby Laboratories (DLB) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Dolby Laboratories and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Dolby Laboratories (DLB) Forecast

Analysts have given Dolby Laboratories (DLB) a Buy based on their latest research and market trends.

According to 4 analysts, Dolby Laboratories (DLB) has a Buy consensus rating as of Oct 15, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $95.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $95.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Dolby Laboratories (DLB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.